Northern Trust Corp Champions Oncology, Inc. Transaction History

Northern Trust Corp

$761 Billion
Q3 2025

A detailed history of Northern Trust Corp transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 46,434 shares of CSBR stock, worth $315,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,434

Previous 53,762 13.63%

Holding current value

$315,286

Previous $396,000 25.25%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$6.16 - $8.91 $45,140 - $65,292	-7,328 Reduced 13.63%	46,434 $296,000
Q2 2025 Aug 13, 2025	SELL	$5.72 - $8.85 $1,144 - $1,770	-200 Reduced 0.37%	53,762 $396,000
Q1 2025 May 13, 2025	SELL	$8.2 - $11.7 $262 - $374	-32 Reduced 0.06%	53,962 $468,000
Q4 2024 Feb 14, 2025	BUY	$3.79 - $8.62 $48,978 - $111,396	12,923 Added 31.47%	53,994 $462,000
Q3 2024 Nov 13, 2024	BUY	$3.95 - $5.14 $2,401 - $3,125	608 Added 1.5%	41,071 $200,000

Q2 2024 Aug 14, 2024	SELL	$4.5 - $5.23 $10,017 - $11,641	-2,226 Reduced 5.21%	40,463 $209,000
Q1 2024 May 14, 2024	SELL	$4.9 - $6.91 $10,917 - $15,395	-2,228 Reduced 4.96%	42,689 $209,000
Q4 2023 Feb 13, 2024	BUY	$4.56 - $6.59 $63,370 - $91,581	13,897 Added 44.8%	44,917 $252,000
Q3 2023 Nov 13, 2023	SELL	$5.2 - $7.32 $1,440 - $2,027	-277 Reduced 0.89%	31,020 $192,000
Q2 2023 Aug 11, 2023	BUY	$4.11 - $6.81 $10,320 - $17,099	2,511 Added 8.72%	31,297 $199,000
Q1 2023 May 15, 2023	BUY	$4.0 - $4.67 $2,692 - $3,142	673 Added 2.39%	28,786 $115,000
Q4 2022 Feb 13, 2023	BUY	$3.75 - $7.69 $172 - $353	46 Added 0.16%	28,113 $126,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $9.47 $5,494 - $7,216	762 Added 2.79%	28,067 $210,000
Q2 2022 Aug 12, 2022	SELL	$6.81 - $8.31 $871 - $1,063	-128 Reduced 0.47%	27,305 $218,000
Q1 2022 May 13, 2022	SELL	$7.26 - $8.53 $312 - $366	-43 Reduced 0.16%	27,433 $223,000
Q4 2021 Feb 08, 2022	SELL	$7.76 - $10.23 $3,041 - $4,010	-392 Reduced 1.41%	27,476 $230,000
Q3 2021 Nov 15, 2021	BUY	$9.11 - $10.96 $1,357 - $1,633	149 Added 0.54%	27,868 $285,000
Q2 2021 Aug 13, 2021	SELL	$8.45 - $11.72 $517,342 - $717,545	-61,224 Reduced 68.84%	27,719 $285,000
Q1 2021 May 12, 2021	SELL	$10.61 - $13.75 $194,353 - $251,872	-18,318 Reduced 17.08%	88,943 $1.01 Million
Q4 2020 Feb 11, 2021	SELL	$8.39 - $13.27 $36,957 - $58,454	-4,405 Reduced 3.94%	107,261 $1.16 Million
Q3 2020 Nov 16, 2020	BUY	$7.05 - $10.2 $383,435 - $554,757	54,388 Added 94.95%	111,666 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$6.65 - $9.84 $199,041 - $294,521	29,931 Added 109.45%	57,278 $548,000
Q4 2019 Feb 14, 2020	BUY	$5.12 - $8.33 $2,058 - $3,348	402 Added 1.49%	27,347 $227,000
Q3 2019 Nov 13, 2019	SELL	$5.4 - $8.99 $5,940 - $9,889	-1,100 Reduced 3.92%	26,945 $152,000
Q1 2019 May 13, 2019	BUY	$7.89 - $12.23 $2,485 - $3,852	315 Added 1.14%	28,045 $275,000
Q4 2018 Feb 12, 2019	BUY	$7.29 - $15.27 $14,784 - $30,967	2,028 Added 7.89%	27,730 $217,000
Q3 2018 Nov 14, 2018	BUY	$5.82 - $17.47 $149,585 - $449,013	25,702 New	25,702 $449,000

Others Institutions Holding CSBR

# of Institutions

Shares Held

5.69M

Call Options Held

Put Options Held

View Full List

About CHAMPIONS ONCOLOGY, INC.

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $91.8M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

More about CSBR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Champions Oncology, Inc. Transaction History